IP Library › Granted Patent US 11,034,673
Granted Patent B2
US 11,034,673 · App. 16/893,502 · Granted Jun 15, 2021

(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations

Inventors: Pranav Gupta (Basking Ridge, NJ); Jiansheng Wan (Shanghai, CN)
Assignee: Merck Sharp & Dohme Corp.
C07D401/14A61K9/4833A61K9/4866A61K31/444
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,034,673
App. No.
16/893,502
Granted
Jun 15, 2021
Kind
B2
Abstract

A composition comprising (S)—N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide and hypromellose acetate succinate for pharmaceutical preparations, especially capsule preparations.

Claims (1)

1. A compound being (S)—N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide HCl form 1, wherein said compound is characterized by an X-ray powder diffraction spectra having 2-theta values of 3.99, 16.00, 17.78, and 18.81.

Assignments (2)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2020
From: GUPTA, PRANAV; WAN, JIANSHENG
To: MERCK SHARP & DOHME CORP
Reel/Frame 052848/0021 →
Continuity (4)
Continuation 16789123 · Feb 12, 2020
Division 15536496
Provisional Application 62093607 · Dec 18, 2014
Related Publication 20200299266A1 · Sep 24, 2020